Comparative evaluation of different doses of green tea extract alone and in combination with sulfasalazine in experimentally induced inflammatory bowel disease in rats

Digestive Diseases and Sciences

Volumn 56, Issue 5, 2011, Pages 1369-1378

  Byrav, D S Prasad ^a   Medhi, B ^a   Vaiphei, K ^a   Chakrabarti, A ^a   Khanduja, K L ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Crohn's disease; Interleukin 1; Malondialdehyde; Myeloperoxidase; Tumor necrosis factor; Ulcerative colitis

Indexed keywords

GREEN TEA EXTRACT; MALONALDEHYDE; MYELOPEROXIDASE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; CERVICAL SPINE DISLOCATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; ENTERITIS; FEMALE; HISTOLOGY; HISTOPATHOLOGY; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CAMELLIA SINENSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; INFLAMMATORY BOWEL DISEASES; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; PEROXIDASE; PLANT EXTRACTS; RATS; RATS, WISTAR; SULFASALAZINE; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79955638413     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1446-4     Document Type: Article

References (22)

1. Friedman S, Blumberg S. Inflammatory Bowel Disease. In: Kasper DL, Braunwald U, Fauci AS, Hauser SL, Longo DL, Jameson JL, eds. Harrison's principles of internal medicine. 16th ed. New York: McGraw-Hill; 2005:1776-1788.
2. Kenneth M, Mc Quid MD. Alimentary tract. In: Lawrence MT, Stephen J, Macphee, Maxine A, Papadakis, eds. Current medical diagnosis and treatment. 42nd ed. Chicago: McGraw Hill; 2003:602-611.
3. Palmer KR, Penman ID. Disease of the alimentary tracts and pancrease. In: Haslett C, Chilvers ER, Hunter JAA, Boon NA, eds. Davidson's principle and practice of medicine. 18th ed. United Kingdom: Churchill Livingstone; 1999:659-668.
4. Marcel WL. Pharmacological effects of green tea on the gastrointestinal system. Rev Eur J Pharmacol. 2004;500:177-185.
5. Varilek GW, Yang F, Lee EY, de Villiers WJ, Zhong J, Oz HS. Green tea polyphenol extract attenuates inflammation in interleukin-2-deficient mice, a model of autoimmunity. J Nutr. 2001;131:2034-2039. (Pubitemid 32661076)
6. Yang F, Oz HS, Barve S, de Villiers WJ, McClain CJ, Varilek GW. The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol Pharmacol. 2001;60:528-533. (Pubitemid 32781560)
7. Moser G, Tillinger W, Sachs G, et al. Relationship between the use of unconventional therapies and disease-related concerns: a study of patients with inflammatory bowel disease. J Psychosom Res. 1996;40:503-509. (Pubitemid 26174492)
8. Hilsden RJ, Scott CM, Verhoef MJ. Complementary medicine use by patients with inflammatory bowel disease. Am J Gastroenterol. 1998;93:697-701. (Pubitemid 29063905)
9. Yang F, de Villiers WJ, McClain CJ, Varilek GW. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J Nutr. 1998;128(12):2334-2340. (Pubitemid 29012980)
10. Lin YL, Lin JK. Epigallocatechin-3-gallate blocks the induction of nitricoxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-B. Mol Pharmacol. 1997;52:465-472.
11. Ryotaro K, Kuroda S, Ohkishi T, Nakamaru K, Hatakeyama S. Oxazolone-induced colitis in BALB/C mice: a new method to evaluate the efficacy of therapeutic agents for ulcerative colitis. J Pharmacol Sci. 2004;96:307-313. (Pubitemid 40013340)
12. Vogel HG, Goethe JW. Experimental Colitis. Drug discovery and evaluation pharmacological assay. 2nd ed. Germany: Springer; 2002:896-899.
13. Levine A, Kenet G, Bruck R, et al. Effect of heparin on tissue binding activity of fibroblast growth factor and heparin binding epidermal growth factor in experimental colitis in rats. Pediatric Res. 2002;51:635-640. (Pubitemid 34453582)
14. Krawiesz JE, Sharan P, Stenson WF. Quantitative assay to acute intestinal inflammation based on myeloperoxidase activity: assessment of inflammation in rat and hamster model. Gastroenterol. 1984;87:1344-1350. (Pubitemid 15201434)
15. Ohkawa H, Ohishi N, Yoge K. Assay of lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Bio Chem. 1978;95:351-358. (Pubitemid 9194347)
16. Morris GP, Rebeiro L, Herride MM, Szewczuk M, Depew W. An animal model of chronic granulomatous inflammation of stomach and colon. Gastroenterol. 1985;86:1188.
17. Wallace JL, Hgaboam CM, Mc knight GW. PAF mediates gastric damage induced by hemorrhagic shock. Am J Physiol. 1990;259:140-146.
18. Pizarro TT, Michie MH, Bentz M, et al. IL-18, a noval immunoregulatory cytokine, is upregulated in Crohn's disease: expression and localization in intestinal mucosal cells. J Immunol. 1999;162:6829-6835. (Pubitemid 29309411)
19. Jiao H-L, Ping Y, Zhao B-L. Protective effects of green tea polyphenols on human HepG2 cells against oxidative damage of fenofibrate. Free Radic Biol Med. 2003;35:1121-1128. (Pubitemid 37315704)
20. Suske G. The Sp-family of transcription factors. Gene. 1999;238:291-300. (Pubitemid 29446168)
21. Pazdrak K, Shi X-Z, Sarna SK. TNF-α suppresses human colonic circular smooth muscle cell contractility by SP1- and NF-κB-mediated induction of ICAM-1. Gastroenterol. 2004;127:1096-1109. (Pubitemid 39345879)
22. Muller C. Tumour necrosis factor in mouse models of chronic intestinal inflammation. Immunonol. 2002;105:1-8.